Genetic characterization of Swedish patients with familial hypercholesterolemia: a heterogeneous pattern of mutations in the LDL receptor gene

被引:18
|
作者
Lind, S [1 ]
Rystedt, E
Eriksson, M
Wiklund, O
Angelin, B
Eggertsen, G
机构
[1] Huddinge Univ Hosp, Karolinska Inst, Dept Med Lab Sci & Technol, Ctr Inherited Metab Dis, S-14186 Huddinge, Sweden
[2] Huddinge Univ Hosp, Karolinska Inst, Dept Med Lab Sci & Technol, Div Clin Chem, S-14186 Huddinge, Sweden
[3] Huddinge Univ Hosp, Karolinska Inst, Dept Med, Ctr Metab & Endocrinol, S-14186 Huddinge, Sweden
[4] Huddinge Univ Hosp, Karolinska Inst, Mol Nutr Unit, Ctr Metab & Endocrinol, S-14186 Huddinge, Sweden
[5] Gothenburg Univ, Sahlgrens Hosp, Wallenberg Lab Cardiovasc Res, Dept Med, S-41345 Gothenburg, Sweden
关键词
familial hypercholesterolemia; LDL receptor gene mutations; apo B-100;
D O I
10.1016/S0021-9150(02)00038-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Familial hypercholesterolemia (FH) is an autosomal codominant disease, caused by mutations in the LDL receptor gene. To characterize the distribution of genetic aberrations in Swedish FH-patients fulfilling the clinical criteria of FH, we have investigated 150 unrelated Swedish patients for mutations in the LDL receptor gene and for the most common mutation causing familial ligand defective apo B-100 (FDB). Of the patients, 77 were recruited from Huddinge University Hospital in Stockholm and 73 from Sahlgren's University Hospital in Goteborg. Screening was carried out using SSCP and Southern blotting techniques, combined with DNA sequence analysis. In total, mutations regarded as cause for disease were identified in 55 patients (37%), representing 32 different types of mutations. In the LDL receptor gene we detected four nonsense mutations, 13 missense mutations, seven splice junction mutations, and four major rearrangements. In addition, two small deletions were identified and one base exchange in the promoter region. The most common mutation (apo B3500) causing FDB was found in three patients. The most frequent mutation was FH-Helsinki, reflecting the admixture of Finnish immigrants. We further identified 15 point mutations which were not considered to affect the function of the gene, and thus were regarded as polymorphic changes. This multitude of mutations reflects a heterogeneous genetic background in our series of Swedish FH-patients and differs from the situation in the other Scandinavian countries. Future studies should aim at characterizing the importance of other genes for the development of the FH phenotype. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:399 / 407
页数:9
相关论文
共 50 条
  • [21] Regulation of the LDL receptor in familial hypercholesterolemia
    Soutar, Anne K.
    CLINICAL LIPIDOLOGY, 2009, 4 (06) : 755 - 765
  • [22] CHARACTERIZATION OF 3 MUTATIONS OF THE LOW-DENSITY-LIPOPROTEIN RECEPTOR GENE IN ITALIAN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
    LELLI, N
    GHISELLINI, M
    GUALDI, R
    TIOZZO, R
    CALANDRA, S
    GADDI, A
    CIARROCCHI, A
    ARCA, M
    FAZIO, S
    COVIELLO, DA
    BERTOLINI, S
    ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (02): : 234 - 243
  • [23] "Finnish" Mutations in LDL Receptor Gene: A Rare Cause of Familial Hypercholesterolemia in St. Petersburg and Petrozavodsk
    Komarova, T. Yu.
    Golovina, A. S.
    Grudinina, N. A.
    Zakharova, F. M.
    Korneva, V. A.
    Lipovetskii, B. M.
    Serebrenitskaya, M. P.
    Konstantinov, V. O.
    Vasilyev, V. B.
    Mandelshtam, M. Yu.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2013, 155 (03) : 380 - 383
  • [24] Spectrum of LDL receptor gene mutations in Denmark:: implications for molecular diagnostic strategy in heterozygous familial hypercholesterolemia
    Jensen, HK
    Jensen, LG
    Meinertz, H
    Hansen, PS
    Gregersen, N
    Færgeman, O
    ATHEROSCLEROSIS, 1999, 146 (02) : 337 - 344
  • [25] Phenotypic variation in heterozygous familial hypercholesterolemia - A comparison of Chinese patients with the same or similar mutations in the LDL receptor gene in China or Canada
    Pimstone, SN
    Sun, XM
    du Souich, C
    Frohlich, JJ
    Hayden, MR
    Soutar, AK
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (02) : 309 - 315
  • [26] INFLUENCE OF SPECIFIC MUTATIONS AT THE LDL-RECEPTOR GENE LOCUS ON THE RESPONSE TO SIMVASTATIN THERAPY IN AFRIKANER PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    JEENAH, M
    SEPTEMBER, W
    VANROGGEN, FG
    DEVILLIERS, W
    SEFTEL, H
    MARAIS, D
    ATHEROSCLEROSIS, 1993, 98 (01) : 51 - 58
  • [27] Screening for genetic mutations in LDLR gene with familial hypercholesterolemia patients in the Saudi population
    Alharbi, Khalid Khalaf
    Kashour, Tarek S.
    Al-Hussaini, Wejdan
    Nbaheen, May Salem
    Hasanato, Rana M. W.
    Mohamed, Sarar
    Tamimi, Waleed
    Khan, Imran Ali
    ACTA BIOCHIMICA POLONICA, 2015, 62 (03) : 559 - 562
  • [28] Intronic mutations outside of Alu-repeat-rich domains of the LDL receptor gene are a cause of familial hypercholesterolemia
    Sabine Amsellem
    Dorothée Briffaut
    Alain Carrié
    Jean Rabès
    Jean Girardet
    Alexandre Fredenrich
    Philippe Moulin
    Michel Krempf
    Yves Reznik
    Bernard Vialettes
    Jean de Gennes
    Eric Brukert
    Pascale Benlian
    Human Genetics, 2002, 111 : 501 - 510
  • [29] Low density lipoprotein-receptor (LDL-R) gene mutations among Filipinos with familial hypercholesterolemia
    Punzalan, FER
    Sy, RG
    Santos, RS
    Cutiongco, EM
    Gosiengfiao, S
    Fadriguilan, E
    George, P
    Laurie, A
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2005, 12 (05) : 276 - 283
  • [30] Low density lipoprotein receptor gene mutations in patients with clinical diagnosis of familial hypercholesterolemia
    Meshkov, AN
    Stambolsky, DV
    Krapivner, SR
    Bochkov, VN
    Kukharchuk, VV
    Malyshev, PP
    KARDIOLOGIYA, 2004, 44 (09) : 58 - 61